DIRS.INFO The most relevant business & tech news

☆ The Question of Transgender Care - The New York Times
▼ + stars: | 2024-04-18 | by ( David Brooks | ) www.nytimes.com time to read: +2 min

It is about what the health care approach should be, and how best to help the growing number of children and young people who are looking for support from the N.H.S. For reasons that are also not clear, adolescents who were assigned female at birth are driving this trend, whereas before the late 2000s, it was mostly adolescents who were assigned male at birth who sought these treatments. One is that greater social acceptance of trans people has enabled people to seek these therapies. A third is that the rise of teen mental health issues may be contributing to gender dysphoria. In her report, Cass is skeptical of broad generalizations in the absence of clear evidence; these are individual children and adolescents who take their own routes to who they are.

Persons: Hilary Cass, Cass Organizations: National Health Service, Britain’s Royal College of Pediatrics, Child Locations: England, Cass

☆ Scotland Pauses Gender Medications for Minors
▼ + stars: | 2024-04-18 | by ( Azeen Ghorayshi | ) www.nytimes.com time to read: 1 min

Scotland’s National Health Service has stopped all new prescriptions of puberty-blocking drugs and other hormone treatments for minors, citing a sweeping review of youth gender services released in England last week. It is the sixth country in Europe to limit such treatments, and its changes are among the most restrictive. England and carried out by Dr. Hilary Cass, an independent pediatrician, over the course of four years, concluded that the evidence for benefits of youth gender treatments was “remarkably weak” and that pressing questions remained about potential long-term risks. This month, following recommendations by Dr. Cass, N.H.S. Hormone therapies, including estrogen and testosterone, are still available to teenagers in England aged 16 and up.

Persons: Hilary Cass, . Cass Organizations: Health Service, N.H.S Locations: England, Europe, N.H.S

☆ England Limits Youth Gender Medications, Part of Big Shift in Europe
▼ + stars: | 2024-04-09 | by ( Azeen Ghorayshi | ) www.nytimes.com time to read: +1 min

The National Health Service in England started restricting gender treatments for children this month, making it the fifth European country to limit the medications because of a lack of evidence of their benefits and concern about long-term harms. England’s change resulted from a four-year review released Tuesday evening by Dr. Hilary Cass, an independent pediatrician. “For most young people, a medical pathway will not be the best way to manage their gender-related distress,” the report concluded. In a related editorial published in a medical journal, Dr. Cass said the evidence that youth gender treatments were beneficial was “built on shaky foundations.”The N.H.S. England’s move is part of a broader shift in northern Europe, where health officials have been concerned by soaring demand for adolescent gender treatments in recent years.

Persons: Dr, Hilary Cass, Cass Organizations: National Health Service Locations: England, Europe

The UK government has promised to overhaul the youth gender care system, after it was deemed inadequate by England’s regulator of health and social care. They described a deeply flawed system that is now hobbled by a toxic political climate around gender care. The letter said a decision would be made at some point from early 2022 on whether the child “is likely to meet the access criteria” for gender care. The family has received no NHS gender care or mental health support since the referral, she said. These recommended supporting “identity exploration” and mental health treatment as the first steps to ensure that any psychological issues are addressed.

Search resuls for: "Hilary Cass"

4 mentions found